July 10, 2024Journal of HypertensionOpen Access

Whole -genome survival analysis of 144 286 people from the UK Biobank identifies novel loci associated with blood pressure

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Randomized trial identifies genetic variants associated with hypertension, suggesting therapeutic targets.

Novel loci associated with hypertension were identified, revealing significant variant-level associations among 6,319,822 analyzed single nucleotide polymorphisms.
Among 31 significant variants, 29 were identified as novel, particularly in the genes Fibrillin-2 and Junctophilin-2, strengthening the genetic understanding of hypertension.
Analysis utilized whole-genome sequencing data and time-to-event data from UK Biobank participants over a 12-year follow-up period, emphasizing extensive genetic exploration for hypertension links and mechanisms involved in high blood pressure regulation and responses to therapies influences with association periods of 12 years and longitudinal assessment of participant health outcomes in Genotype analyses of FBN2 and JPH2 expression levels. Understanding these associations may enable targeted interventions for managing hypertension effectively.

Saluja et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark